Eagle Pharmaceuticals Inc

Eagle Pharmaceuticals Inc is a leading specialty pharmaceutical company that specializes in the development and commercialization of injectable products for critical care and oncology. The company's primary focus is on creating innovative formulations of existing drugs to enhance patient outcomes and reduce healthcare costs. With a diverse portfolio of products, including oncology support, critical care, and orphan disease products, Eagle Pharmaceuticals is dedicated to improving patient care by addressing unmet medical needs. The company's flagship product, Ryanodex, is a life-saving treatment for malignant hyperthermia, a rare and life-threatening condition that can occur during anesthesia. Headquartered in Woodcliff Lake, New Jersey, Eagle Pharmaceuticals has a strong presence in the United States and Europe, and is committed to advancing patient care through the development and commercialization of innovative products.